As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
North America is anticipated to be a key regional market for ethosuximide during the forecast period. The rise in the number of people affected by absence seizures is driving the ethosuximide industry. The increased usage of the drug by the pharmaceutical industry within India and China is contributing to the Asia Pacific market growth. The growing investments into the healthcare and pharmaceutical sectors to propel the market growth in the regions. The growing penetration and rising presence of the key players in the industry are further propelling the market growth in regions like the Asia Pacific. Major players like Pfizer are looking to expand their R&D capabilities in Asia, which is likely o aid the market growth in the coming years.
Ethosuximide has been listed as an essential medicine by the World Health Organization. The rising health consciousness and product awareness among consumers is the key trend of the market. In 2020, Strides Pharma Science Ltd (NSE: STAR) announced that it had received approval for Ethoxusimide Softgel Capsules USP, 250mg from the United States Food & Drug Administration (USFDA). Thus, the rising approval of the product by various government organisations is expected to propel the growth of the market in the coming years.
Market Analysis by Form, Application, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global ethosuximide market are Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.